- Phone
-
Address
904, 9th Floor, Building 4, No. 8 Development Road, Changping District, Beijing
Beijing Heyi Biotechnology Co., Ltd
904, 9th Floor, Building 4, No. 8 Development Road, Changping District, Beijing
TargetMolDomestic agent for biological reagents
TargetMolOriginating from Massachusetts, the core area of biomedicine in the United States,We have grown into a supplier in the field of screening compounds, providing high-quality small molecule compound and drug screening services to over 500 universities, research institutes, and enterprises. With solid practical experience, we have won wide trust in the scientific research field.
In response to the problem of cumbersome collection of small molecules in drug development and resource waste caused by small experimental quantities,TargetMolLaunch a rich compound library, covering more than 160 compound libraries that meet different research and development needs, including over 12000 inhibitors, over 16000 natural products, as well as diversified biochemical reagents such as peptides, antibodies, and life science kits. The product is supplied in flexible specifications such as 1mg, 5mg dry powder, and 10mM solution, providing biologists and pharmacists with clear activity and toxicity of marketed drug research small molecules and inhibitor resources. It efficiently supports experiments such as cell signal transduction, cell induction, new use of old drugs, and positive controls, greatly saving the time and cost of researchers and significantly improving research and development efficiency.
TargetMolProvide over 20000 small molecule compounds targeting various signaling pathways and targets, which can be accurately used for research on cell signal transduction, enzyme activity regulation, etc., providing core tools for drug target validation and mechanism exploration.Supply over 19000 natural products and their derivatives, sourced from plants, microorganisms, etc., suitable for natural medicine chemistry research and biological activity screening, assisting in the exploration and development of natural active ingredients.
We can provide over 7300 peptides and peptide related products, focusing on popular targets such as GLP-1R, FPR2, TLR2, INSR, PI3K, etc., and selecting high-purity peptide molecules.For example, Semaglutide, Tirzepatide and Liraglutide are suitable for the study of metabolic diseases such as diabetes and obesity.Like UrocortinCeruletideUsed for the study of mechanisms related to the nervous system and gastrointestinal function,Pam3CSK4, LL-37, D-GsMTx4, help explore immune regulation and inflammatory mechanisms,It is widely used in diabetes, obesity, cardiovascular, inflammation, autoimmunity, nervous system diseases and antibacterial mechanism research, covering experimental scenarios such as signal pathway verification, disease model construction, pharmacological mechanism exploration, etc.
TargetMolDomestic agent for biological reagents
Beijing and a providerTargetMolThe full line of products, some of which are as follows:
name |
Item Number |
brand |
specification |
Daraxonrasib |
T74698 |
TargetMol |
1mg |
RMC-7977 |
T81263 |
TargetMol |
1mg |
Erastin |
T1765 |
TargetMol |
1 mg * 200 |
Azelaprag |
T14390 |
TargetMol |
25 mg |
Trastuzumab deruxtecan |
T36646 |
TargetMol |
5 mg |
Heritage deruxtecan |
T77910 |
TargetMol |
10 mg |
Glembatumumab Vedotine |
T74178 |
TargetMol |
5 mg |
IL-23 Protein, Mouse, Recombinant (His) |
TMPY-03526 |
TargetMol |
200 μg |
|
IFN gamma Protein, Mouse, Recombinant (E. coli)
|
TMPS-00156 |
TargetMol |
10 μg |
Natural product derivative library |
NY1000 |
TargetMol |
10 μLx 10 mM (in DMSO) |
Human endogenous metabolic compound library |
L2500 |
TargetMol |
1 mg |
TargetMolAlways taking it as our responsibility to support scientific research and innovation. Whether it's helping drug development overcome bottlenecks or supporting basic biological research to explore the unknown,TargetMolEveryone is willing to become a solid partner of scientific researchers, using high-quality products and professional services to shorten the research and development cycle and improve research and development efficiency.